SARAH SHRINER: Open Payments
NPI 1710539879 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,937 in 124 payments from 17 companies in 2025. Trend: 2023 $1,465 · 2024 $1,424 · 2025 $1,937
Food & beverage: $1,937
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $431 |
| Janssen Biotech, Inc. | 33 | $327 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $266 |
| Lilly USA, LLC | 7 | $191 |
| PFIZER INC. | 9 | $135 |
| GENZYME CORPORATION | 4 | $92 |
| Regeneron Healthcare Solutions, Inc. | 5 | $89 |
| Aimmune Therapeutics, Inc. | 4 | $85 |
| Celltrion USA Inc. | 4 | $70 |
| Ipsen Biopharmaceuticals, Inc | 4 | $55 |
Products named: TREMFYA, SKYRIZI, ENTYVIO, OMVOH, DUPIXENT, RINVOQ, ZENPEP, VELSIPITY.
Industry payments across KS — which companies pay providers there.
